ADVANCED WOUND MANAGEMENT

C-section Surgery

As the most common, increasingly frequent surgical procedure globally, C-section surgery has the potential to disrupt early bonding between parent and baby.1-3 With a high risk of surgical site complications (SSCs), it may lead to serious consequences for both patients and clinicians1-6

PICO-OBGYN-Global-HERO-840x840-PX.png

C-Section Surgery

Understanding C-section wound complications

With superficial SSIs potentially leading to a risk of deep incision infection, organ space infection and endometritis, additional patient care intensifies financial and clinical challenges in the hospital and the community.1,5

  • A median 4 days longer in hospital for patients who develop a SSI, bearing associated costs7

  • Poorer outcomes for patients with risk factors such as pre-pregnancy obesity (BMI ≥30), with a substantially higher risk of SSI1-3

  • Extended hospital stays or readmissions may cause anxiety, with the potential to obstruct valuable bonding time and breastfeeding6


Consider: How many C-section patients have a BMI ≥30 and are at greater risk of SSI?

Protecting time to bond

Clinical evidence has demonstrated how prophylactic use of the PICO◊ Single Use Negative Pressure Wound Therapy System (sNPWT) may help reduce the prevalence and impact of SSCs, particularly in patients with a BMI ≥30, compared to standard dressings.4

  • 50% relative risk reduction in the incidence of SSI, compared to standard care*4

  • Estimated mean cost saving of €339 per SSI patient with a pre-pregnancy BMI ≥35, compared to standard care5

  • Patients who received PICO sNPWT following a C-section were more satisfied with the overall cosmetic appearance of the scar at 30 days and six months**8

PICO-system.png

Products

Products

Medical Education

No results.
See all the other courses we have
View all courses

Reference Materials

Disclaimers

*Compared to care with standard dressings; n=32; p<0.001.

**Compared to standard dressings. The Patient Scar Assessment Scale overall opinion, 30 days: n=205, p=0.018; six months: n=190, p=0.043; PICO is not a scar treatment, but rather helps prevent scar formation / aid in scar appearance, by aiding with the prevention of surgical site complications / wound healing.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.

Citations

1. Wloch C, et al. BJOG: An International Journal of Obstetrics & Gynaecology. 2012 Oct;119(11):1324-33.

2. Leth RA, et al. Acta obstetricia et gynecologica Scandinavica. 2011 May;90(5):501-9.

3. Schneid-Kofman N, et al. International Journal of Gynecology & Obstetrics. 2005 Jul;90(1):10-5.6.

4. Hyldig N, et al. BJOG: An International Journal of Obstetrics & Gynaecology. 2019 Apr;126(5):628-35.

5. Hyldig N, et al. BJOG: An International Journal of Obstetrics & Gynaecology. 2019 Apr;126(5):619-27.

6. Bullough L, et al. The Clinical Services Journal. 2015:2-6.

7. Jenks PJ, et al. Journal of Hospital Infection. 2014 Jan 1;86(1):24-33.

8. Hyldig N, et al. Ann Plast Surg. 2020;85(6):1–7.

9. Hudson DA, et al. Int Wound J. 2015;12(2):195-201.

10. Smith+Nephew 2019. Internal Report. RD/18/134 V2.

11. Smith+Nephew 2017. Internal Report. DS/17/253/R.

12. Smith+Nephew 2018. Internal Report. RD/18/133.

Title

Text

Explore